by Will Rinehart
American Action Forum
July 31, 2014
Companies across the U.S. are meeting health challenges head on by investing in time, talent, and materials. U.S. federal law has long protected these endeavors through the intellectual property (IP) regime. Understanding the process of innovation in both health and medicine requires a basic knowledge of three areas: the legal underpinnings of patent law, the economics of patents, and how the two interact within a company. Today, we cannot forget just how important these laws have been in creating and sustaining the technological sectors, especially those where innovation is especially costly. A basic overview of intellectual property rights (IPR) in innovative industries, particularly in medical treatments, is a beginning point to explore where the regime has gotten things right.



Heritage FoundationInsiderOnline is a product of The Heritage Foundation.
214 Massachusetts Avenue NE | Washington DC 20002-4999
ph 202.546.4400 | fax 202.546.8328
© 1995 - 2014 The Heritage Foundation